Skip to main content
Erschienen in:

01.11.2007 | Original Contributions

Follow-Up After Curative Resection of Colorectal Cancer: A Meta-Analysis

verfasst von: Joe J. Tjandra, M.D., F.R.A.C.S., Miranda K. Y. Chan, M.B.B.S., F.R.A.C.S.

Erschienen in: Diseases of the Colon & Rectum | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This is a systematic review to evaluate the impact of various follow-up intensities and strategies on the outcome of patients after curative surgery for colorectal cancer.

Methods

All randomized trials up to January 2007, comparing different follow-up intensities and strategies, were retrieved. Meta-analysis was performed by using the Forest plot review.

Results

Eight randomized, clinical trials with 2,923 patients with colorectal cancer undergoing curative resection were reviewed. There was a significant reduction in overall mortality in patients having intensive follow-up (intensive vs. less intensive follow-up: 21.8 vs. 25.7 percent; P--.01). Regular surveillance with serum carcinoembryonic antigen (P--.0002) and colonoscopy (P--.04) demonstrated a significant impact on overall mortality. However, cancer-related mortality did not show any significant difference. There was no significant difference in all-site recurrence and in local or distant metastasis. Detection of isolated local and hepatic recurrences was similar. Intensive follow-up detected asymptomatic recurrence more frequently (18.9 vs. 6.3 percent; P-lt;-.00001) and 5.91 months earlier than less intensive follow-up protocol; these were demonstrated with all investigation strategies used. Intensive surveillance program detected recurrences that were significantly more amenable to surgical reresection (10.7 vs. 5.7 percent; P--.0002). The chance of curative reresection were significantly better with more intensive follow-up (24.3 vs. 9.9 percent; P--.0001), independent of the investigation strategies used.

Conclusions

Intensive follow-up after curative resection of colorectal cancer improved overall survival and reresection rate for recurrent disease. However, the cancer-related mortality was not improved and the survival benefit was not related to earlier detection and treatment of recurrent disease.
Literatur
1.
Zurück zum Zitat Jemal A, Murray T, Samuels, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5–26.CrossRefPubMed Jemal A, Murray T, Samuels, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5–26.CrossRefPubMed
2.
Zurück zum Zitat Bohm B, Schwenk W, Hucke HP, Stock W. Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma? Dis Colon Rectum 1993;36:280-.CrossRefPubMed Bohm B, Schwenk W, Hucke HP, Stock W. Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma? Dis Colon Rectum 1993;36:280-.CrossRefPubMed
3.
Zurück zum Zitat Kjeldsen BJ, Kronborg O, Fenger C, Jorgensen OD. The pattern of recurrent colorectal cancer in a prospective randomized study and the characteristics of diagnostic tests. Int J Colorectal Dis 1997;12:329-4.CrossRefPubMed Kjeldsen BJ, Kronborg O, Fenger C, Jorgensen OD. The pattern of recurrent colorectal cancer in a prospective randomized study and the characteristics of diagnostic tests. Int J Colorectal Dis 1997;12:329-4.CrossRefPubMed
4.
Zurück zum Zitat Figueredo A, Rumble RB, Maroun J, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 2003;3:26.CrossRefPubMed Figueredo A, Rumble RB, Maroun J, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 2003;3:26.CrossRefPubMed
5.
Zurück zum Zitat Taylor I. Quality of follow-up of the cancer patient affecting outcome. Surg Oncol Clin N Am 2000;9:21-.PubMed Taylor I. Quality of follow-up of the cancer patient affecting outcome. Surg Oncol Clin N Am 2000;9:21-.PubMed
6.
Zurück zum Zitat Berman JM, Cheung RJ, Weinberg DS. Surveillance after colorectal cancer resection. Lancet 2000;355:395-.CrossRefPubMed Berman JM, Cheung RJ, Weinberg DS. Surveillance after colorectal cancer resection. Lancet 2000;355:395-.CrossRefPubMed
7.
Zurück zum Zitat Huang A, Hindle KS, Tsavellas G. Colorectal cancer surveillance post-surgery. Hosp Med (London) 2001;62:490-. Huang A, Hindle KS, Tsavellas G. Colorectal cancer surveillance post-surgery. Hosp Med (London) 2001;62:490-.
8.
Zurück zum Zitat Johnson FE, Virgo KS, Fossati R. Follow-up for patients with colorectal cancer after curative-intent primary treatment. J Clin Oncol 2004;22:1363-.CrossRefPubMed Johnson FE, Virgo KS, Fossati R. Follow-up for patients with colorectal cancer after curative-intent primary treatment. J Clin Oncol 2004;22:1363-.CrossRefPubMed
10.
11.
Zurück zum Zitat Meyerhardt JA, Mayer RJ. Follow-up strategies after curative resection of colorectal cancer. Sem Oncol 2003;30:349-0.CrossRef Meyerhardt JA, Mayer RJ. Follow-up strategies after curative resection of colorectal cancer. Sem Oncol 2003;30:349-0.CrossRef
12.
Zurück zum Zitat Northover J. Follow-up after curative surgery for colorectal cancer. Scand J Surg 2003;92:84-.PubMed Northover J. Follow-up after curative surgery for colorectal cancer. Scand J Surg 2003;92:84-.PubMed
13.
14.
Zurück zum Zitat Pfister DG, Benson AB 3rd, Somerfield MR. Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. N Engl J Med 2004;350:2375–82. Pfister DG, Benson AB 3rd, Somerfield MR. Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. N Engl J Med 2004;350:2375–82.
15.
Zurück zum Zitat Richard CS, McLeod RS. Follow-up of patients after resection for colorectal cancer: a position paper of the Canadian Society of Surgical Oncology and the Canadian Society of Colon and Rectal Surgeons. Can J Surg 1997;40:90–100.PubMed Richard CS, McLeod RS. Follow-up of patients after resection for colorectal cancer: a position paper of the Canadian Society of Surgical Oncology and the Canadian Society of Colon and Rectal Surgeons. Can J Surg 1997;40:90–100.PubMed
16.
Zurück zum Zitat Bruinvels DJ, Stigglebout AM, Kievet J, Van Houwelingen HC, Habberma JD, Velde CJVan de. Follow-up of patients with colorectal cancer: a meta-analysis. Ann Surg 1994;219:174-2.CrossRefPubMed Bruinvels DJ, Stigglebout AM, Kievet J, Van Houwelingen HC, Habberma JD, Velde CJVan de. Follow-up of patients with colorectal cancer: a meta-analysis. Ann Surg 1994;219:174-2.CrossRefPubMed
17.
Zurück zum Zitat Rosen M, Chan L, Beart RW Jr, Vukasin P, Anthone G. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum 1998;41:1116-6.CrossRefPubMed Rosen M, Chan L, Beart RW Jr, Vukasin P, Anthone G. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum 1998;41:1116-6.CrossRefPubMed
18.
Zurück zum Zitat Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. The Cochrane Database of Systematic Reviews (Oxford) 2002;1:ID #CD002200 Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. The Cochrane Database of Systematic Reviews (Oxford) 2002;1:ID #CD002200
19.
Zurück zum Zitat Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Impact on survival of intensive follow-up after curative resection for colorectal cancer: systematic review and meta-analysis of randomized trials. BMJ 2002;324:813-.CrossRefPubMed Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Impact on survival of intensive follow-up after curative resection for colorectal cancer: systematic review and meta-analysis of randomized trials. BMJ 2002;324:813-.CrossRefPubMed
20.
Zurück zum Zitat Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Mechanisms of improved survival from intensive follow-up in colorectal cancer: a hypothesis. Br J Cancer 2005;92:430-.PubMed Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Mechanisms of improved survival from intensive follow-up in colorectal cancer: a hypothesis. Br J Cancer 2005;92:430-.PubMed
21.
Zurück zum Zitat Renehan AG, O’Dwyer ST, Whynes DK. Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. BMJ 2004;328:81-.CrossRefPubMed Renehan AG, O’Dwyer ST, Whynes DK. Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. BMJ 2004;328:81-.CrossRefPubMed
22.
Zurück zum Zitat Makela J, Laitinen S, Kairaluoma MI. Early results of follow-up after radical resection for colorectal cancer. Preliminary results of a prospective randomized trial. Surg Oncol 1992;1:157-1.CrossRefPubMed Makela J, Laitinen S, Kairaluoma MI. Early results of follow-up after radical resection for colorectal cancer. Preliminary results of a prospective randomized trial. Surg Oncol 1992;1:157-1.CrossRefPubMed
23.
Zurück zum Zitat Makela JT, Seppo OL, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Arch Surg 1995;130:1062-.PubMed Makela JT, Seppo OL, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Arch Surg 1995;130:1062-.PubMed
24.
Zurück zum Zitat Ohlsson B, Breland U, Ekberg H. Follow-up after curative surgery for colorectal carcinoma. Dis Colon Rectum 1995;38:619-6.CrossRef Ohlsson B, Breland U, Ekberg H. Follow-up after curative surgery for colorectal carcinoma. Dis Colon Rectum 1995;38:619-6.CrossRef
25.
Zurück zum Zitat Kjeldsen BJ, Kronborg O, Fenger C. A prospective randomised study of follow-up after radical surgery for colorectal cancer. Br J Surg 1997;84:666-.CrossRefPubMed Kjeldsen BJ, Kronborg O, Fenger C. A prospective randomised study of follow-up after radical surgery for colorectal cancer. Br J Surg 1997;84:666-.CrossRefPubMed
26.
Zurück zum Zitat Pietra N, Sarli L, Costi R. Role of follow-up in management of local recurrences of colorectal cancer. Dis Colon Rectum 1998;41:1127-3.CrossRefPubMed Pietra N, Sarli L, Costi R. Role of follow-up in management of local recurrences of colorectal cancer. Dis Colon Rectum 1998;41:1127-3.CrossRefPubMed
27.
Zurück zum Zitat Schoemaker D, Black R, Giles L. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gasteroenterology 1998;114:7–14CrossRef Schoemaker D, Black R, Giles L. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gasteroenterology 1998;114:7–14CrossRef
28.
Zurück zum Zitat Graber MA. Appropriate follow up of patients with colon cancer. J Fam Pract 1998;46:353-.PubMed Graber MA. Appropriate follow up of patients with colon cancer. J Fam Pract 1998;46:353-.PubMed
29.
Zurück zum Zitat Wattchow DA, Weller D, Pilotto L, et al. Randomized controlled trial (RCT) comparing hospital and general practice based follow-up of patients with colon cancer. ANZ J Surg 2002;72(Suppl):A22 Wattchow DA, Weller D, Pilotto L, et al. Randomized controlled trial (RCT) comparing hospital and general practice based follow-up of patients with colon cancer. ANZ J Surg 2002;72(Suppl):A22
30.
Zurück zum Zitat Secco GB, Fardelli R, Gianquinto D. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 2002;28:418-3.CrossRefPubMed Secco GB, Fardelli R, Gianquinto D. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 2002;28:418-3.CrossRefPubMed
31.
Zurück zum Zitat Grossmann EM, Johnson FE, Virgo KS, Longo WE, Fossati R. Follow-up of colorectal cancer patients after resection with curative intent: the GILDA trial. Surg Oncol 2004;13:119-4.CrossRefPubMed Grossmann EM, Johnson FE, Virgo KS, Longo WE, Fossati R. Follow-up of colorectal cancer patients after resection with curative intent: the GILDA trial. Surg Oncol 2004;13:119-4.CrossRefPubMed
32.
Zurück zum Zitat Rodriguez-Moranta F, Salo J, Arcusa A, et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 2006;24:386-3.CrossRefPubMed Rodriguez-Moranta F, Salo J, Arcusa A, et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 2006;24:386-3.CrossRefPubMed
33.
Zurück zum Zitat Vernava AM, Longo WE, Virgo KS, Coplin MA, Wade TP, Johnson FE. Current follow-up strategies after resection of colon cancer. Results of a survey of members of The American Society of Colon and Rectal Surgeons. Dis Colon Rectum 1994;37:573-3.CrossRefPubMed Vernava AM, Longo WE, Virgo KS, Coplin MA, Wade TP, Johnson FE. Current follow-up strategies after resection of colon cancer. Results of a survey of members of The American Society of Colon and Rectal Surgeons. Dis Colon Rectum 1994;37:573-3.CrossRefPubMed
34.
Zurück zum Zitat Edelman MJ, Meyers FJ, Siegel D. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Int Med 1997;12:318-1.CrossRef Edelman MJ, Meyers FJ, Siegel D. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Int Med 1997;12:318-1.CrossRef
35.
Zurück zum Zitat Schwartz D, Billingsley K, Wallner K. Follow-up care for cancer: making the benefits equal the cost. Oncol 2000;14:1501-. Schwartz D, Billingsley K, Wallner K. Follow-up care for cancer: making the benefits equal the cost. Oncol 2000;14:1501-.
36.
Zurück zum Zitat Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports on randomized clinical trials: Is blinding necessary? Cont Clin Trials 1996;17:1–12.CrossRef Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports on randomized clinical trials: Is blinding necessary? Cont Clin Trials 1996;17:1–12.CrossRef
37.
Zurück zum Zitat Review Manager. RevMan user guideline, [computer program] version 4.2 for windows. Oxford, England: The Cochrane Collaboration, 2002. Review Manager. RevMan user guideline, [computer program] version 4.2 for windows. Oxford, England: The Cochrane Collaboration, 2002.
38.
Zurück zum Zitat Barillari P, Ramacciato G, Manetti G, Borino A, Sammartino P, Stipa V. Surveillance of colorectal cancer: effectiveness of early detection of intraluminal recurrences on prognosis and survival of patients treated for cure. Dis Colon Rectum 1996;39:388-3.CrossRefPubMed Barillari P, Ramacciato G, Manetti G, Borino A, Sammartino P, Stipa V. Surveillance of colorectal cancer: effectiveness of early detection of intraluminal recurrences on prognosis and survival of patients treated for cure. Dis Colon Rectum 1996;39:388-3.CrossRefPubMed
39.
Zurück zum Zitat Sano Y, Fujii T, Oda Y, et al. A multicenter randomized controlled trial designed to evaluate follow-up surveillance strategies for colorectal cancer: The Japan Polyp Study. Dig Endosc 2004;16:376-.CrossRef Sano Y, Fujii T, Oda Y, et al. A multicenter randomized controlled trial designed to evaluate follow-up surveillance strategies for colorectal cancer: The Japan Polyp Study. Dig Endosc 2004;16:376-.CrossRef
40.
Zurück zum Zitat Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ. Changes in diet, physical activity, and supplement use among adults diagnosed with cancers. J Am Diet Assoc 2003;103:323-.PubMed Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ. Changes in diet, physical activity, and supplement use among adults diagnosed with cancers. J Am Diet Assoc 2003;103:323-.PubMed
41.
Zurück zum Zitat Anonymous. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. GIVIO Investigators. JAMA 1994;271:1587-2CrossRef Anonymous. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. GIVIO Investigators. JAMA 1994;271:1587-2CrossRef
42.
Zurück zum Zitat Kuchler T, Henne-Burns D, Rappat S, et al. Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology 1999;46:3. Kuchler T, Henne-Burns D, Rappat S, et al. Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology 1999;46:3.
43.
Zurück zum Zitat Kronborg O. Optimum follow-up in colorectal cancer patients: what tests and how often? Sem Surg Oncol 1994;1:217-4.CrossRef Kronborg O. Optimum follow-up in colorectal cancer patients: what tests and how often? Sem Surg Oncol 1994;1:217-4.CrossRef
44.
Zurück zum Zitat Kievit J. Colorectal cancer follow-up: a reassessment of empirical evidence on effectiveness. Eur J Sur Oncol 2000;26:322-.CrossRef Kievit J. Colorectal cancer follow-up: a reassessment of empirical evidence on effectiveness. Eur J Sur Oncol 2000;26:322-.CrossRef
45.
Zurück zum Zitat Lennon T, Houghton J, Northover J. What is the value of clinical follow-up for colorectal cancer patients? The experience of the CRC/NIH CEA Second Look Trial. Nottingham, England International Colorectal Cancer Symposium 1995. Available at: http://www.york.ac.uk/inst/crd/ehc36.pdf. Accessed May 1, 2005 Lennon T, Houghton J, Northover J. What is the value of clinical follow-up for colorectal cancer patients? The experience of the CRC/NIH CEA Second Look Trial. Nottingham, England International Colorectal Cancer Symposium 1995. Available at: http://​www.​york.​ac.​uk/​inst/​crd/​ehc36.​pdf. Accessed May 1, 2005
46.
Zurück zum Zitat Cunliffe WJ, Hasleton PS, Tweedle DE, Schofield PF. Incidence of synchronous and metachronous colorectal carcinoma. Br J Surg 1984;71:941-.CrossRefPubMed Cunliffe WJ, Hasleton PS, Tweedle DE, Schofield PF. Incidence of synchronous and metachronous colorectal carcinoma. Br J Surg 1984;71:941-.CrossRefPubMed
47.
Zurück zum Zitat Obrand DI, Gordon PH. Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum 1997;40:15–25.CrossRefPubMed Obrand DI, Gordon PH. Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum 1997;40:15–25.CrossRefPubMed
48.
Zurück zum Zitat Kraemer M, Wiratkapun S, Seow-Choen F, Ho YH, Eu KW, Nyam D. Stratifying risk factors for follow-up: a comparison of recurrent and non recurrent colorectal cancer. Dis Colon Rectum 2001;44:815-1.CrossRefPubMed Kraemer M, Wiratkapun S, Seow-Choen F, Ho YH, Eu KW, Nyam D. Stratifying risk factors for follow-up: a comparison of recurrent and non recurrent colorectal cancer. Dis Colon Rectum 2001;44:815-1.CrossRefPubMed
49.
Zurück zum Zitat Delpero JR, Pol B, Le Treut P, et al. Surgical resection of locally recurrent colorectal recurrent colorectal adenocarcinoma. Br J Surg 1998;85:372-.CrossRefPubMed Delpero JR, Pol B, Le Treut P, et al. Surgical resection of locally recurrent colorectal recurrent colorectal adenocarcinoma. Br J Surg 1998;85:372-.CrossRefPubMed
50.
Zurück zum Zitat Loprinzi CL, Hayes D, Smith T. Doc, shouldn’t we be getting some tests? J Clin Oncol 2000;18:2345-.PubMed Loprinzi CL, Hayes D, Smith T. Doc, shouldn’t we be getting some tests? J Clin Oncol 2000;18:2345-.PubMed
51.
Zurück zum Zitat Stiggelbout AM, de Haes JC, Vree R, et al. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer 1997;75:914-0.PubMed Stiggelbout AM, de Haes JC, Vree R, et al. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer 1997;75:914-0.PubMed
52.
Zurück zum Zitat Kjeldsen BJ, Thorsen H, Whalley D, Kronborg O. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol 1999;34:509-5.CrossRefPubMed Kjeldsen BJ, Thorsen H, Whalley D, Kronborg O. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol 1999;34:509-5.CrossRefPubMed
53.
Zurück zum Zitat Anonymous. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol 1992;10:904-1 Anonymous. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol 1992;10:904-1
54.
Zurück zum Zitat Cunningham D, Pyrhonen S, James RD, et al. Randomized trials of irinotecan plus supportive care versus supportive care alone after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 1998;352:1413-.CrossRefPubMed Cunningham D, Pyrhonen S, James RD, et al. Randomized trials of irinotecan plus supportive care versus supportive care alone after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 1998;352:1413-.CrossRefPubMed
55.
Zurück zum Zitat Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2000;343:905-4.CrossRefPubMed Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2000;343:905-4.CrossRefPubMed
56.
Zurück zum Zitat Schorr M, Siebeck M, Zoller WC. Colorectal cancer: a rational follow up program adapted to patient’s individual risk of recurrence. Z Gastroenterol 1997;35:1019-7PubMed Schorr M, Siebeck M, Zoller WC. Colorectal cancer: a rational follow up program adapted to patient’s individual risk of recurrence. Z Gastroenterol 1997;35:1019-7PubMed
57.
Zurück zum Zitat Earle CC, Grunfeld E, Coyle D, Cripps MC, Stern HS. Cancer physicians-attitudes toward colorectal cancer follow up. Ann Oncol 2003;14:400-.CrossRefPubMed Earle CC, Grunfeld E, Coyle D, Cripps MC, Stern HS. Cancer physicians-attitudes toward colorectal cancer follow up. Ann Oncol 2003;14:400-.CrossRefPubMed
Metadaten
Titel
Follow-Up After Curative Resection of Colorectal Cancer: A Meta-Analysis
verfasst von
Joe J. Tjandra, M.D., F.R.A.C.S.
Miranda K. Y. Chan, M.B.B.S., F.R.A.C.S.
Publikationsdatum
01.11.2007
Verlag
Springer-Verlag
Erschienen in
Diseases of the Colon & Rectum / Ausgabe 11/2007
Print ISSN: 0012-3706
Elektronische ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-007-9030-5

Weitere Artikel der Ausgabe 11/2007

Diseases of the Colon & Rectum 11/2007 Zur Ausgabe

Neu im Fachgebiet Chirurgie

Vier Kriterien sprechen für ein erhöhtes Risiko nach Appendektomie

17.07.2024 Appendektomie Nachrichten

Um bei Kindern den Schweregrad einer Appendizitis und drohende Komplikationen richtig einzuschätzen, können sich Chirurginnen und Chirurgen auf die intraoperativen Kriterien des US-amerikanischen NSQIP Pediatric stützen.

Partielle Nephrektomie: Videoanalysen zur Verbesserung der chirurgischen Qualität

16.07.2024 Nephrektomie Nachrichten

Je versierter Operateurinnen und Operateure sind, desto geringer ist das Risiko für Komplikationen. Eine kleine US-Studie spricht dafür, dass das auch bei Roboter-assistierten Nephrektomien gilt – und dass sich Op.-Videos für die Beurteilung eignen.        

Thrombolyse während der PCI hilft STEMI-Patienten

08.07.2024 ST-Hebungsinfarkt Nachrichten

Patienten mit ST-Hebungsinfarkten, die während der perkutanen Koronarintervention einer intrakoronaren Thrombolyse unterzogen werden, müssen weniger ernste kardiale Komplikationen fürchten. Das Blutungsrisiko steigt dadurch offenbar nicht.

„Wir brauchen eine indikationsgerechte Adipositastherapie“

03.07.2024 Adipositas Nachrichten

Die Adipositas ist eine häufige Erkrankung, mit der sich Patienten in der Hausarztpraxis vorstellen. Für die Behandlung stehen Ernährungs- und Bewegungstherapie, medikamentöse Ansätze und Chirurgie zur Verfügung. Die Therapie muss indikationsgerecht erfolgen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.